A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot was higher than antibodies in people who had been infected with and recovered naturally from COVID-19.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3